You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 18, 2024

Details for Patent: 10,426,743


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,426,743 protect, and when does it expire?

Patent 10,426,743 protects VTAMA and is included in one NDA.

This patent has forty-five patent family members in thirty-five countries.

Summary for Patent: 10,426,743
Title:Topical pharmaceutical compositions
Abstract: The present invention relates to topical pharmaceutical emulsion compositions comprising a therapeutically effective amount of 3,5-Dihydroxy-4-isopropyl-trans-stilbene or a pharmaceutically acceptable salt thereof, an oil phase, a water phase, a surfactant, and an antioxidant, and wherein the emulsion composition is homogeneous and/or the active is solubilized in the oil phase. The invention also relates to methods of treating a dermatological condition or disorder in a patient by administering the present compositions to the skin of the patient.
Inventor(s): Sonti; Sujatha D. (Collegeville, PA), Thomas; Joey Roger (Clayton, NC), Lenn; Jon (Durham, NC), Santos; Leandro (King of Prussia, PA), Whiteman; Justin (Raleigh, NC), Doherty; Michael Quinn (Hillsborough, NC), Bedard; Mary (King of Prussia, PA), Jain; Piyush (Chester Springs, PA)
Assignee: DERMAVANT SCIENCES GMBH (Basel, CH)
Application Number:16/255,121
Patent Claim Types:
see list of patent claims
Use; Composition;

Drugs Protected by US Patent 10,426,743

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Dermavant Sci VTAMA tapinarof CREAM;TOPICAL 215272-001 May 23, 2022 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial TOPICAL TREATMENT OF PLAQUE PSORIASIS IN ADULTS ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,426,743

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 104699 ⤷  Try a Trial
Australia 2016263161 ⤷  Try a Trial
Australia 2019203627 ⤷  Try a Trial
Brazil 112017024934 ⤷  Try a Trial
Canada 2986251 ⤷  Try a Trial
Chile 2017002939 ⤷  Try a Trial
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.